| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.008 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.008 |